A kind of preparation method for the β-carboline compound of anti-renal fibrosis drug and/or anti-chronic kidney disease drug
A technology for chronic kidney disease and renal fibrosis, which is applied in the field of preparation of β-carboline compounds, can solve the problems of low yield, difficulty, and harsh reaction conditions, and achieve the effects of high yield, simple operation, and mild reaction conditions
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Preparation of 1-pyridine-6-methoxy-9-(2-methylbenzyl)-β-carboline
[0023] Palladium acetate 0.2g (1mmol), silver oxide 0.93g (4mmol) and alkali 3.18g (sodium carbonate 30mmol), 1-pyridine-6-methoxy-β-carboline 2.75g (10mmol) were added to the In the reaction flask of acetonitrile, drop the acetonitrile solution of substituted benzyl bromide (containing 2.4g of 2-methylbenzyl bromide), raise the temperature to 45°C, stir and react for 1-2h, cool to room temperature after the reaction, extract with ethyl acetate, wash with water , concentrated, recrystallized from dichloromethane / n-hexane (1:10), dried to obtain 3.57g of 1-pyridine-6-methoxy-9-(2-methylbenzyl)-β-carboline, and the yield was 94.2%, purity 99.19% (HPLC area normalization method). 1 HNMR (300MHz, DMSO-d 6 ): δ8.66(d, 1H), 8.52(d, 1H), 8.04(d, 1H), 7.71~7.67(m, 1H), 7.59~7.54(m, 1H), 7.37(d, 1H), 7.33(d, 1H), 7.24(d, 1H), 6.98~6.84(m, 2H), 6.76~6.70(m, 1H), 6.46(d, 1H), 5.49(s, 2H), 4.04(s, 3H), 2.13(s,...
Embodiment 2
[0025] Preparation of 1-pyridine-6-methoxy-9-(3-methylbenzyl)-β-carboline
[0026] 2.2g (10mmol) of palladium acetate, 4.6g (20mmol) of silver oxide, 65.2g (cesium carbonate 200mmol) and 13.8g (50mmol) of 1-pyridine-6-methoxy-β-carboline were added to the Into a reaction flask of acetonitrile, drop the acetonitrile solution of substituted benzyl bromide (containing 13g of 3-methylbenzyl bromide), raise the temperature to 55°C, stir and react for 1-2h, after the reaction is completed, cool to room temperature, extract with ethyl acetate, concentrate, Washed with water, recrystallized from dichloromethane / n-hexane (1:10), and dried to obtain 18.25 g of 1-pyridine-6-methoxy-9-(3-methylbenzyl)-β-carboline with a yield of 96.2 %, purity 99.47% (HPLC area normalization method). 1 HNMR (300MHz, DMSO-d 6 ): δ8.65(d, 1H), 8.53(d, 1H), 8.05(d, 1H), 7.72~7.68(m, 1H), 7.59~7.54(m, 1H), 7.35(d, 1H), 7.32(d, 1H), 7.22(d, 1H), 6.98~6.85(m, 2H), 6.72(s, 1H), 6.46(d, 1H), 5.45(s, 2H), 3.98(...
Embodiment 3
[0028] Preparation of 1-pyridine-6-methoxy-9-(2,3,4,5-tetrafluorobenzyl)-β-carboline
[0029] Palladium acetate 3.4g (15mmol), silver oxide 6.95g (30mmol) and alkali 42.4g (sodium carbonate 400mmol), 1-pyridine-6-methoxy-β-carboline 27.5g (100mmol) were added to the Into the reaction flask of acetonitrile, then drip the acetonitrile solution of substituted benzyl bromide (containing 26.7g of 2,3,4,5-tetrafluorobenzyl bromide), raise the temperature to 50°C, stir for 1-2h, and cool to room temperature after the reaction is completed. Extracted with ethyl acetate, concentrated, washed with water, recrystallized from dichloromethane / n-hexane (1:10), and dried to obtain 1-pyridine-6-methoxy-9-(2,3,4,5-tetrafluorobenzyl )-β-carboline 41g, yield 93.7%, purity 99.33% (HPLC area normalization method). 1 HNMR (300MHz, DMSO-d 6 )δ9.56(d, J=5.1Hz, 1H), 9.51(dt, J=4.9, 1.2Hz, 1H), 9.04(d, J=5.1Hz, 1H), 7.79–7.75(m, 2H), 7.66(t, J=1.5Hz, 1H), 7.35–7.30(m, 1H), 7.23(d, J=1.5Hz, 2H), 6.09...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
